Screening for MRSA in ICU patients. How does PCR compare with culture?

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Diagnostic Technologies

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat in healthcare settings.
• Rapid detection of MRSA nasal carriage is crucial for infection control and prevention of spread.
• Polymerase chain reaction (PCR) offers a potential method for faster MRSA identification.

Purpose of the Study:

• To compare the efficacy of culture-based methods with real-time PCR for detecting MRSA in an intensive care unit (ICU) pilot study.
• To evaluate the time to detection and diagnostic accuracy of each method.
• To assess the clinical utility of PCR in optimizing antibiotic therapy.

Main Methods:

• A pilot study was conducted in a general ICU between October and November 2005.
• 170 swabs from 63 patients were analyzed using Columbia Blood Agar, CHROMagar MRSA, and real-time PCR (IDI-MRSA assay).
• Swabs were collected on admission and twice weekly.

Main Results:

• Five previously unknown MRSA-positive patients were identified; PCR initially detected only three.
• CHROMagar MRSA provided the quickest culture-based detection (80% of MRSA).
• Real-time PCR offered rapid results (2.25 hours) and aided antibiotic therapy optimization in two patients, but was less specific and more costly than CHROMagar MRSA.

Conclusions:

• Real-time PCR facilitates rapid MRSA detection, potentially aiding in preventing its spread.
• PCR should be used in conjunction with traditional culture methods for comprehensive MRSA screening.
• The study highlights the trade-offs between speed, specificity, and cost in MRSA diagnostic techniques.